IgA nephropathy is the most common glomerular disease worldwide, yet there is no international
consensus for its pathological or clinical classification. Here a new classification for IgA …

Pathological classifications in current use for the assessment of glomerular disease have
been typically opinion-based and built on the expert assumptions of renal pathologists about …

Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST
scores have been increasingly used in clinical practice. Further retrospective cohort studies …

Proteinuria has been shown to be an adverse prognostic factor in IgA nephropathy. The benefit
of achieving a partial remission of proteinuria, however, has not been well described. We …

Background/Aims: Pimagedine inhibits the formation of advanced glycation end products
and slows the progression of diabetic complications in experimental models. This study was …

Autoantibodies to the M-type phospholipase A 2 receptor (PLA 2 R) are sensitive and specific
for idiopathic membranous nephropathy. The anti-B cell agent rituximab is a promising …

… MGN such as the drugs phenytoin and gold salts, immunologic conditions such as systemic
lupus erythematosus (SLE), and infections, including malaria and hepatitis B and hepatitis C. …

Immunoglobulin A (IgA) nephropathy is one of the most common primary types of
glomerulonephritis to progress to end-stage renal disease. Its variable and often long natural history …

The KDIGO guideline for glomerulonephritis is designed to assist health-care providers in
treating patients with glomerular diseases. A guideline is not a set of rules but is intended to …

… Author links open overlay panel Daniel C. Cattran 1 2 3 4 5 6 7 , Gerald B. Appel 1 2 3 4 5 6
… Overall, however, a loss of 50% of renal function as measured by the halving of baseline C …